So the page has turned from JPM and next is earnings and the usual rush of secondaries. Remember, however, that we had lot of secondaries to end the year, so perhaps the end of January will not be as flush with cash raising as in previous years. Earnings will likely be a little anti-climatic as […]
January 15th Biotech Update
So JPM is done and it was the least eventful one I can remember. I am still a little surprised that the sector has done this well. Usually post JPM we see a flood of secondaries and I suspect there will be an uptick in the next couple weeks. That being said we ended last […]
January 13th Biotech Update
So I think JPM is a complete failure in terms of news. It is obviously a dud in terms of M&A. I do not remember the last time we had a JPM with zero mergers. There have been some with minor deals but it has been awhile since there have not been any. This actually […]
January 4th Biotech Update
Volume and the market news should start to pick up this week as people get back from the holiday but keep in mind that JPM is next week, so I would not expect a ton of biotech news. Most of the biotech news should be speculation heading into JPM and the news that could be […]
December 17th Biotech Update
I am a little surprised at the lack of follow through after Monday. I expected the potential of a small retracement but then strength to return to the sector. I am not willing to say the trading is indicating a near term top is in for the sector as we are still in a seasonally […]
December 16th Biotech Update
Well, we have had two red days in a row after Monday’s move. I noted that we should be setup for a rally into the end of the year and that anything other than that bodes poorly in the near term. So is it time to call it and in the short term? Not quite […]
December 10th Biotech Update
The sector is clearly doing well and there is some interesting news that perhaps bodes well heading into JPM and the end of the year. We are not quite making news highs again today but the sector is feeling like it wants to and it really stands in stark contrast to the pandemic and economy. […]
APLIF – Appili Therapeutics and Avigan the Antiviral Pill to Treat Coronavirus
Canada TSX: APLI, US OTC: APLIF Recent vaccine news from Pfizer (PFE) and Moderna (MRNA) provide some optimism to a world suffering from disease, death, and lockdown, and desperately looking for a solution to the COVID-19 pandemic for a return to normal life and work. Safe and effective vaccines will help contain the spread of […]
November 18th Biotech (and MLP) Update
So the market continues to look good including the sector that is pushing all time highs. While I often say the trend is your friend (and it is), it might also be time to pull out another saying. When markets are making all time highs, the most likely outcome is to continue to make marginal […]
October 30 Biotech Update
I said that a kick was possible for the sector and it could be pulling one off. Yesterday ended up better than I expected and was the start of that save but the market remains in a precarious position with anxiety over the election potentially overwhelming everything today. Of course, the consensus seems to be […]
October 29th Biotech Update
As awful as the day was yesterday, the sector is not quite broken. This is not to say that things look great but a reversal and green close today could save it. Another day lower and we can call the trend as it would be a potentially lower low establishing. I am not very optimistic […]
October 23rd Biotech (and MLP) Update
Yesterday, we had a nice follow through rally from the early morning move higher. That was nice to see and could possibly indicate that we are in the making new high phase of the uptrend. We still are in a limit news phase with earnings to start becoming a larger and larger story (at least […]
October 22 Biotech Update
The past couple days have not been great but we still remain in the uptrend and that has to be the assumption until that trend is broken. We are probably at an area where support should happen and a bounce develop. If we continue downward and do not get any real support, it would raise […]
October 16th Biotech (and MLP) Update
Looks like we are going to have a decent end to the week. I am still not sure if the sector is going to continue to push this higher high even higher or we get a pullback to establish a new higher low. It certainly looks like the sector wants to move at least nominally […]
September 24th Biotech Update
We are not quite in trouble with the sector despite the recent sell off and pain. Obviously the broader market is not helping but we have not broken below recent lows and still can reverse (needs to be soon) higher and make a higher high to start a new trend. Of course, nothing is guaranteed […]
September 23 Biotech Update
We could be setting ourselves up for moving to a higher high with the reversal yesterday. While it certainly seems possible, this would also be the potential start of a new trend so I would be cautious in putting too much stock in it until we see some real confirmation. In this case it would […]
September 21 Biotech Update
A weak start to the week and it is not immediately clear the cause. The sector certainly had a decent run last week and a little consolidative pullback is not crazy. The broader markets were weaker last week and so this could be a continuation of that move. I actually sort of like this setup […]
September 17th Biotech Update
The sector has been strong and today is the first real test of this move, although when I say test it is more to see how much stronger it can be. Most of the days this week opened strong and that strength continued but today we open red and so we get to see if […]
September 16 Biotech Update
The early week deals have set a nice rally in the sector which was expected. The positive is that we not only broke above the last lower high but also closed above it. As such, I think it is clear that we have broken the down trend and so the question now is whether we […]
September 14th Biotech Update
We are back baby! This is the M&A that the sector has been wanting. If this cannot break the sector out of the downtrend and push it back to highs (if not higher) then not much else could. The ideal scenario would be a push above the recent lower high today but we were pretty […]
